From the Division of Neurology, Department of Pediatrics, Duke University Children's Hospital and Duke University School of Medicine, Durham, NC.
Neurology. 2020 Feb 18;94(7):326-328. doi: 10.1212/WNL.0000000000008963. Epub 2020 Feb 3.
Childhood-onset dystonias are a heterogeneously diverse group. There exists a specific set of dystonias that respond profoundly well to low doses of l-dopa (dopa-responsive dystonia [DRD]). Classical DRD is caused by deficiency of GTP cyclohydrolase 1 or tyrosine hydroxylase, but other conditions can cause dystonias that are partially responsive to dopamine. The idea of a diagnostic therapeutic trial with l-dopa for children who present with dystonia has been around for decades and is frequently advocated for; however, l-dopa trials are not without risk.
儿童期起病的肌张力障碍是一组异质性很强的疾病。存在一组特定的肌张力障碍,对低剂量左旋多巴(多巴反应性肌张力障碍 [DRD])反应非常好。经典的 DRD 是由 GTP 环水解酶 1 或酪氨酸羟化酶缺乏引起的,但其他情况也可能导致对多巴胺部分反应的肌张力障碍。几十年来,人们一直认为对出现肌张力障碍的儿童进行诊断性治疗试验,用左旋多巴进行治疗;然而,左旋多巴试验并非没有风险。